FDA daily for Monday, November 16, 2026
In this issue: 16 approvals and 212 label changes. 2 items touch categories MedGrid carries, and they come first.
For MedGrid's categories
Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.
- Elta MD UV AOX Eye
ZINC OXIDE · CP Skin Health Group, Inc. · TOPICAL
- ITP DAILY BAWSE CLEAN, TINTED SUNSCREEN SERUM SPF 28 DEW YOU
ZINC OXIDE · In The Pynk LLC · TOPICAL
Drug and biologic approvals
FDA date:On Mon, Nov 9 FDA approved 4 new applications (3 brand or biologic, 1 generic) and 12 supplements to existing ones.
- TOFACITINIB CITRATE
APOTEX · TOFACITINIB CITRATE
- OXDERYS
AVYXA HOLDINGS · DOXORUBICIN HYDROCHLORIDE
- NDA221291
BAYER HEALTHCARE
- MULTIBIC
FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP LLC · MULTIBIC
Label updates
FDA date:212 drug labels took effect on Mon, Nov 2; 5 of the 25 read for this issue are for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.
- Elta MD UV AOX Eye
ZINC OXIDE · CP Skin Health Group, Inc. · TOPICAL
- ITP DAILY BAWSE CLEAN, TINTED SUNSCREEN SERUM SPF 28 DEW YOU
ZINC OXIDE · In The Pynk LLC · TOPICAL
- ITP DAILY BAWSE CLEAN, TINTED SUNSCREEN SERUM SPF 28 ON THE GLOW
ZINC OXIDE · In The Pynk LLC · TOPICAL
- ITP DAILY BAWSE CLEAN, TINTED SUNSCREEN SERUM SPF 28 GOLDEN HOUR
ZINC OXIDE · In The Pynk LLC · TOPICAL
- Illuminating SPF 50 plus drops Broad Spectrum Sunscreen
ZINC OXIDE · Cosmetic Enterprise Ltd · TOPICAL
- Amlodipine and Benazepril Hydrochloride
AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE · PD-Rx Pharmaceuticals, Inc. · ORAL
- vilazodone hydrochloride
VILAZODONE HYDROCHLORIDE · Preferred Pharmaceuticals Inc. · ORAL
- Metformin Hydrochloride
METFORMIN HYDROCHLORIDE · Ascend Laboratories, LLC · ORAL
- Tofacitinib
TOFACITINIB · XLCare Pharmaceuticals Inc · ORAL
- Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE · Ajanta Pharma USA Inc. · ORAL
- Ketorolac Tromethamine
KETOROLAC TROMETHAMINE · Henry Schein, Inc. · INTRAMUSCULAR, INTRAVENOUS
FDA did not answer for Drug shortages, Drug recalls, Clearances, Device recalls, Food and supplement recalls while this issue was written; those sections will fill in on a later visit.
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
